Dashboard
Curated content
Companies
Stats & Insights
Sectors
Investors
Transactions
Multiples
More organizations
News
Deep Dives
Knowledge base
Companies
Sharp Peptide Biotechnology (Dalian) Group
Save
Sharp Peptide Biotechnology (Dalian) Group
Verified
Launch date
Jul 2021
Market cap
-
Net debt
-
Enterprise valuation
$16—24m
(Dealroom.co estimates May 2023.)
Dalian Liaoning (HQ)
Overview
Similar companies
Analytics
Notes
Job openings
Innovations (0)
Sharp Peptide Biotechnology (Dalian) Group funding
Sharp Peptide Biotechnology (Dalian) Group investors
Edit
Date
Investors
Amount
Round
May 2023
*
Sculptor
$4.0m
Series A
Total Funding
000k
Recent News about Sharp Peptide Biotechnology (Dalian) Group
Edit
